IMPFSTOFF-ADJUVANS-FORMULIERUNG

European patent · EP3603619 · In force

Register entry

Publication number
EP3603619
Application number
EP18774978
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 28, 2018
Published
Feb 5, 2020
Granted
Aug 13, 2025
Protection ends at the latest
Mar 27, 2038
Next annual fee due
Mar 31, 2027
IPC classes
A61K 9/127 (2025.01)
A61K 31/505 (2006.01)
A61K 39/00 (2006.01)
A61K 39/39 (2006.01)
A61K 45/00 (2006.01)
A61K 47/06 (2006.01)
A61K 47/24 (2006.01)
A61K 47/28 (2006.01)
A61K 47/54 (2017.01)
A61K 47/69 (2017.01)
A61P 31/00 (2006.01)
A61P 35/00 (2006.01)
A61P 37/04 (2006.01)
Priority
JP 2017066280 29.03.2017
PCT application
PCT/JP2018/012637 28.03.2018
PCT publication
WO2018/181420 04.10.2018
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 24, 2026

    Change

    Published in Swissreg on 24.06.2026

  2. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  3. Oct 1, 2025

    Agent entered

    Representative
    BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 01.10.2025

  4. Aug 13, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 13.08.2025

Parties

Holder

Sumitomo Pharma Co., Ltd.

6-8, Doshomachi 2-chome Chuo-ku, Osaka-shi,, Osaka 541-0045, JP

Agent

BOHEST AG

Holbeinstrasse 36-38, 4051 Basel

Inventor

FUKUSHIMA, Akihisa

Osaka-shi Osaka 554-0022, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.